These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10887041)

  • 1. Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium.
    Rossoni G; Locatelli V; Gennaro Colonna Vd ; Müller EE; Berti F
    Pharmacol Res; 2000 Aug; 42(2):129-36. PubMed ID: 10887041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment.
    Torsello A; Rossoni G; Locatelli V; De Gennaro Colonna V; Bernareggi M; Francolini M; Müller EE; Berti F
    Endocrine; 2001 Feb; 14(1):109-12. PubMed ID: 11322492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats.
    De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE
    J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.
    Rossoni G; De Gennaro Colonna V; Bernareggi M; Polvani GL; Müller EE; Berti F
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):260-5. PubMed ID: 9700988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-independent cardioprotective effects of hexarelin in the rat.
    Locatelli V; Rossoni G; Schweiger F; Torsello A; De Gennaro Colonna V; Bernareggi M; Deghenghi R; Müller EE; Berti F
    Endocrinology; 1999 Sep; 140(9):4024-31. PubMed ID: 10465272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.
    De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
    Eur J Pharmacol; 1997 Sep; 334(2-3):201-7. PubMed ID: 9369349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
    Huang J; Li Y; Zhang J; Liu Y; Lu Q
    Int Heart J; 2017 Apr; 58(2):257-263. PubMed ID: 28321024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model.
    Weekers F; Van Herck E; Isgaard J; Van den Berghe G
    Endocrinology; 2000 Nov; 141(11):3993-9. PubMed ID: 11089529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pretreatment with anipamil on a submaximal calcium paradox in the isolated rat heart.
    Ruigrok TJ; Kirkels JH
    Cardioscience; 1990 Sep; 1(3):213-6. PubMed ID: 2102810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Pulsatile Growth Hormone Secretion and Altered Metabolic Hormones by in Vivo Hexarelin Treatment in Streptozotocin-Induced Diabetic Rats.
    Zhang X; Yang JK; Chen C
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30297647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction.
    Tivesten A; Bollano E; Caidahl K; Kujacic V; Sun XY; Hedner T; Hjalmarson A; Bengtsson BA; Isgaard J
    Endocrinology; 2000 Jan; 141(1):60-6. PubMed ID: 10614623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine-induced myocardial injury in calcium-free perfused rat hearts.
    Vander Heide RS; Ganote CE
    Am J Pathol; 1985 Jan; 118(1):55-65. PubMed ID: 3966537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against cardiovascular damage in rats with isolated growth hormone deficiency.
    De Gennaro Colonna V; Rossoni G; Bernareggi M; Müller EE; Berti F
    Cardiologia; 1997 Nov; 42(11):1165-72. PubMed ID: 9534309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diltiazem on the calcium paradox in isolated rat hearts.
    Meno H; Kanaide H; Nakamura M
    J Pharmacol Exp Ther; 1984 Jan; 228(1):220-4. PubMed ID: 6694104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomy in the post-ischemic metabolic and functional recovery profiles of isolated blood-versus buffer-perfused heart.
    Galiñanes M; Bernocchi P; Argano V; Cargnoni A; Ferrari R; Hearse DJ
    J Mol Cell Cardiol; 1996 Mar; 28(3):531-9. PubMed ID: 9011636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine.
    Xu YJ; Saini HK; Zhang M; Elimban V; Dhalla NS
    Cardiovasc Res; 2006 Oct; 72(1):163-74. PubMed ID: 16901476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.
    Hearse DJ; Ferrari R; Sutherland FJ
    J Mol Cell Cardiol; 1999 Nov; 31(11):1961-73. PubMed ID: 10591023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts.
    Ganote CE; Worstell J; Kaltenbach JP
    Am J Pathol; 1976 Aug; 84(2):327-50. PubMed ID: 941982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart.
    Frascarelli S; Ghelardoni S; Ronca-Testoni S; Zucchi R
    Basic Res Cardiol; 2003 Nov; 98(6):401-5. PubMed ID: 14556085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.